Celldex Therapeutics, Inc.
CLDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$67,044 | -$56,600 | -$53,796 | -$47,092 |
| Dep. & Amort. | $824 | $873 | $867 | $819 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $9,191 | $9,316 | $0 |
| Change in WC | $9,803 | $4,217 | -$8,496 | $7,376 |
| Other Non-Cash | $7,789 | -$1,686 | -$2,263 | $6,421 |
| Operating Cash Flow | -$48,628 | -$44,005 | -$54,372 | -$32,476 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$440 | -$728 | -$265 | -$756 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$55,628 | -$122,258 | -$151,822 | -$129,179 |
| Inv. Sales/Matur. | $116,915 | $172,836 | $195,037 | $153,982 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $60,847 | $49,850 | $42,950 | $24,047 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $774 | $63 | $202 | $386 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $774 | $63 | $202 | $386 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $12,993 | $5,908 | -$11,220 | -$8,043 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $23,044 | $17,136 | $28,356 | $36,399 |
| End Cash | $36,037 | $23,044 | $17,136 | $28,356 |
| Free Cash Flow | -$49,068 | -$44,733 | -$54,637 | -$33,232 |